Connected Drug Delivery Devices Market (By Technology [Bluetooth, NFC], By Product [Connected Sensors, Integrated Connected Devices]; By Technology - Bluetooth, NFC, Other Technologies; By End-user - Healthcare Providers, Homecare Centers) - Global Industry Size, Share, Trends and Forecast 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

The global connected drug delivery devices market is project worth $718.9 Billion in 2026 and the market is projected to showcase 26.1% CAGR during the forecast period. The market is driven by increasing penetration of Internet of Things (IoT) in healthcare sector.

Market Dynamics

Increase in acceptance to technology in healthcare sector is the key reason for the growth of the connected drug delivery devices market. Also, supportive government regulation for healthcare sector is positively impacting the growth of the industry and is expected to push the growth during the forecast period.

Connected drug delivery devices technological innovation that has bridged the unsought gap between healthcare and digital technology. The emergence of these ‘healthcare-cum-technology’ devices have addressed the soaring need for better diagnostics and targeted therapeutic tools. It has outpaced the conventional endoscopy by more convenient capsule endoscopy technology, which has now become the standard for non-invasive diagnosis of motility disorders. Moreover, it not only helps physicians in real-time patient monitoring through remote controlling options, but also works as a dose reminder for the patients. Recent success in targeted drug delivery for diseases such as Crohn’s disease, Colitis and Colon cancer has opened new avenues for connected drug delivery devices.

Market Insights

The global connected drug delivery devices market is expected to register substantial growth in the near future, attributed to an increased collaborations between research institutions and companies, licensing agreements and partnerships amongst companies and augmented R&D investment on connected drug delivery devices. Other factors that drive the connected drug delivery devices market are rising prevalence of motility disorders, colon cancer, sedentary lifestyle, encouraging reimbursement environment, high patient compliance due to minimally invasive techniques, targeted drug delivery, and remote patient monitoring. However, factors such as high costs, limited technical knowledge and the patient’s expectations are likely to restrain the growth of the market.

Market Classification

The global connected drug delivery devices market is segmented into four major segment named product, end-user, technology, and region. On the basis of product the connected drug delivery devices market is segmented into connected sensors and integrated connected devices. These connected sensors are further bifurcated into inhaler sensors and injection sensors, and the integrated connected devices is also further segmented into integrated inhaler, and integrated injection. On the basis of the end-user the global connected drug delivery devices market is segmented into healthcare providers and homecare centers. On the basis of technology, the connected drug delivery devices market is segmented into bluetooth, NFC, other technologies (cellular, low power wide area network) On the basis of region the global connected drug delivery devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2017, North America captured largest revenue share and the region is projected to continue its dominance over the forecast period as the region is highly active towards the adoption of modern technology. Other reason for the growth of the North America connected drug delivery market are high per capita healthcare expenditure, and increasing awareness about the adverse effects of non-adherence to medication.

Europe is projected to be the second fastest-developing market for connected drug delivery devices. Augmented incidence of chronic diseases and incidence of a huge target population base are the key parameter increasing demand for connected drug delivery devices in the region. Asia Pacific, Latin America, and Middle East and Africa, the need for connected drug delivery devices is anticipated to remain low during forecast period. This is due to less awareness of better healthcare facilities.

Report Coverage

Market

Connected Drug Delivery Devices Market

Analysis Period

2016 – 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Product, End-user, Technology  and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, 

Player Profiling, Value Chain Analysis

Market Participants

The major players associated with the connected drug delivery devices market Proteus Digital Health, Propeller Health, Merck, Adherium, and BIOCORP. Most of these enterprises put emphasis on new product launch and technological expansion, mergers & acquisitions, and strategic partnership activities as part of their commercial development strategies. Players associated with connected drug delivery market are continuously focussing on research and development to cater best to the customer and facilitate best technology to healthcare sector.

Market Segmentation

Market By Product

  • Connected Sensors
    • Inhaler Sensors
    • Injection Sensors
  • Integrated Connected Devices
    • Integrated Inhaler
    • Integrated Injection

Market By Technology

  • Bluetooth
  • NFC
  • Other Technologies (Cellular, Low Power Wide Area Network)

Market By End-user

  • Healthcare Providers
  • Homecare Centers

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Minimally Invasive Surgical Instruments Market (By Device: Handheld Instruments, -Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices; By Application: Cardiac, Gastrointestinal, Orthopedic, Vascular, Gynecological, Urological, Thoracic, Cosmetic, Dental, Others; By End-user: Hospitals & Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global minimally invasive surgical instruments is market size is anticipated to around USD 39.0 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The inclination for Minimally Invasive Surgical (MIS) techniques is increasing as they are less traumatic and they encourage quicker recoup process than

NET Treatment Market (By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Others; By Site: Lungs, Pancreas, Colon, Small Intestine, Others; By End-user: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global NET treatment is market size is anticipated to around USD 4.2 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The market is driven by growing occurrence of cancer among patients is expected to drive NET treatment market growth across the global.

Embolic Protection Devices Market (By Product: Distal Occlusion Filters, Proximal Occlusion Filters, Distal Filters; By Application: Neurovascular Diseases, Cardiovascular Diseases, Peripheral Vascular Diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global embolic protection devices market size is anticipated to reach USD 2.0 billion by 2026, registering at a CAGR growth of 9.2% over the forecast period. Increasing cases of cardiovascular, neurovascular surgeries and also surge in huge investments in R&D of embolic devices are the main features driving the market development.

Cart Summary